This episode features an interview with Jen Jones and Cody Fair from Noom Health. Jen is the Director of Clinical Solutions and supports teams with alignment on client needs and clinical programs. Cody serves as the Chief Commercial Officer leading the company’s commercial division and drives growth initiatives across all segments.

In this episode, Kirk, Jen, and Cody explore the importance of integrating GLP-1 medications with behavior change programs, challenges related to yo-yo dieting and coverage, and how Noom Health employs tools like body scans and AI to enhance user engagement and outcomes.

-------

“ There's just an incredible level of frustration at the employer level right now because they genuinely want to do something obviously, that is helping their employees and their members. They want to be able to provide these medications that they know can be incredibly effective. But at the same time, they have to be good stewards of the business and the cost. And that's again, really where the two come together is being able to provide a patient experience and benefit, but weighing that against the cost. And so trying to find a solution that allows them to go down that middle road where they can control the cost, but still allow an ideal patient experience and have the access to medications that can be effective.” – Jen Jones

“ What AI will allow us to do is to mine these massive data sets and really start to understand human behavior deeper to where we'll know the exact time that I should reach out to this individual with the exact note that I should send them to make sure we kind of keep them on the program, so to speak. For that person that's going to fall off the wagon and we're never going to see him again. It will give us the ability to figure out the times that we should reach out and how we should reach out and that type of messaging. Something that just pure human intervention would not be able to deliver.” – Cody Fair

-------

Episode Timestamps:

*(01:01): Jen and Cody’s journeys to Noom Health

*(06:02): The importance of behavior change 

*(16:38: The role of GLP-1 medications

*(25:33): Managing GLP-1 costs and access

*(34:59): The future of GLP-1s and Noom Health

*(38:05): Leveraging AI for better health outcomes

-------

Links:

Connect with Jen on LinkedIn

Connect with Cody on LinkedIn

Connect with Kirk on LinkedIn

Learn more about Collective Health